Results

OSTEO-ARTICULAR CLINICAL EVALUATION RESULTS
DendrisKIT OA : Clinical study – Dendris / INOVIE group

February to November 2022

360 samples tested (99 patients)

Aim : Analyze the concordance and performance of DendrisKIT OA against conventional bacteriological methods.

Sampling : Dendris’ technology was carried out using residues of samples from orthopedic surgery departments recovered from the INOVIE-CBM Muret laboratory (31).

Hypothesis : Techniques are considered to be concordant if they have at least one bacterium in common.

The results are 74% concordant between the laboratory method and the DendrisKIT OA. In addition, the kit found a higher proportion of Staphylococcus spp (19 samples) and Cutibacterium acnes (13 samples) verified at 90% by sequencing.

DERMATOPHYTES STUDY RESULTS
DendrisKIT DP : Preliminary study – Dendris / INOVIE group v1.0

June to October 2022

119 samples tested

Aim : Analyze the concordance and performance of DendrisKIT DP against conventional microbiological methods.

Sampling : Dendris’ technology was carried out from different types of samples collected from the CBM Muret (31) and Labosud Montpellier (34) laboratories: residual samples and swabs from the infected area by surface sampling.

Hypothesis : Techniques are considered to be concordant if they have at least one pathogen in common.

The results are 76% concordant between the laboratory method and the DendrisKIT DP. In addition, the kit found a higher proportion of Trichophyton rubrum (13 samples). First sequencing results are already very promising (in progress).